These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3880801)

  • 1. In vitro generation of procoagulant activity by Corynebacterium parvum-stimulated mononuclear leukocytes.
    Miragliotta G; Marcuccio C; Ricci G; Barone G; Fumarola D
    J Leukoc Biol; 1985 Jan; 37(1):101-8. PubMed ID: 3880801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Corynebacterium parvum on Escherichia coli infection in mice.
    Yoshikai Y; Miake S; Mituyama M; Nomoto K
    J Gen Microbiol; 1982 Dec; 128(12):2857-63. PubMed ID: 6763935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corynebacterium parvum: immunomodulation in local bacterial infections.
    Calhoun K; Trachtenberg L; Hart K; Polk HC
    Surgery; 1980 Jan; 87(1):52-8. PubMed ID: 6985758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoattractant properties of Corynebacterium parvum and pyran copolymer for human monocytes and neutrophils.
    Majeski JA; Stinnett JD
    J Natl Cancer Inst; 1977 Mar; 58(3):781-3. PubMed ID: 839571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased susceptibility to Escherichia coli infection in mice pretreated with Corynebacterium parvum.
    Yoshikai Y; Miake S; Sano M; Nomoto K
    Microbiol Immunol; 1983; 27(3):273-82. PubMed ID: 6348489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantity and function of pulmonary alveolar macrophages after splenectomy and Corynebacterium parvum.
    Cioffi WG; Hebert JC; Gamelli RL; Foster RS
    J Trauma; 1985 May; 25(5):405-9. PubMed ID: 3999160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corynebacterium parvum (Propionibacterium acnes): an inducer of tumor necrosis factor-alpha in human peripheral blood mononuclear cells and monocytes in vitro.
    Rossol S; Voth R; Brunner S; Müller WE; Büttner M; Gallati H; Meyer zum Büschenfelde KH; Hess G
    Eur J Immunol; 1990 Aug; 20(8):1761-5. PubMed ID: 1698632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
    Lichtenstein AK; Berek J; Kahle J; Zighelboim J
    Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.
    Hirt HM; Schwenteck M; Becker H; Kirchner H
    Clin Exp Immunol; 1978 Jun; 32(3):471-6. PubMed ID: 688696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of Corynebacterium parvum and Corynebacterium liquefaciens on antitumor activity against sarcoma-180.
    Ideda H; Yamagata S; Toge T; Hattori T
    Gan; 1977 Apr; 68(2):233-5. PubMed ID: 892298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect between neutrophils and Corynebacterium parvum in the process of macrophage activation.
    Chapes SK; Haskill S
    Cancer Res; 1984 Jan; 44(1):31-4. PubMed ID: 6228293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipid A of endotoxin in the production of tumour necrosis factor.
    Ha DK; Leung SW; Fung KP; Choy YM; Lee CY
    Mol Immunol; 1985 Mar; 22(3):291-4. PubMed ID: 4000132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Corynebacterium parvum on colony-stimulating factor and granulocyte-macrophage colony formation.
    Foster RS; MacPherson BR; Browdie DA
    Cancer Res; 1977 May; 37(5):1349-55. PubMed ID: 300651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenicity of Corynebacterium parvum for mouse lymphocytes.
    Zola H
    Clin Exp Immunol; 1975 Dec; 22(3):514-21. PubMed ID: 817854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
    Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
    J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli.
    Gordon DL; Rice JL; McDonald PJ
    Immunology; 1989 Aug; 67(4):460-5. PubMed ID: 2527804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
    Gauthier-Rahman S
    Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.